Combination chemotherapy for Human Immunodeficiency Virus-1
- 1 May 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 102 (5) , 76-80
- https://doi.org/10.1016/s0002-9343(97)00068-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Viral Counts Count in HIV InfectionScience, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In VitroThe Journal of Infectious Diseases, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Drug Resistance and Heterogeneous Long-Term Virologic Responses of Human Immunodeficiency Virus Type 1-Infected Subjects to Zidovudine and Didanosine Combination TherapyThe Journal of Infectious Diseases, 1995
- Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human PlasmaAIDS Research and Human Retroviruses, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseNature, 1993
- Combination Therapy with Zidovudine and Dideoxycytidine in Patients with Advanced Human Immunodeficiency Virus InfectionAnnals of Internal Medicine, 1992
- High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionNew England Journal of Medicine, 1991